{
    "2018-12-21": [
        [
            {
                "time": "2018-01-02",
                "original_text": "AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Approval",
                        "RA",
                        "Upadacitinib"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Noteworthy Friday Option Activity: CLVS, ABBV, AAL",
                "features": {
                    "keywords": [
                        "Option Activity",
                        "CLVS",
                        "ABBV",
                        "AAL"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "various"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Gilead Partners with Scholar Rock for Fibrotic Disease Drugs",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Scholar Rock",
                        "Fibrotic",
                        "Disease",
                        "Drugs"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}